Edition:
United Kingdom

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

6.60USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$6.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,015
52-wk High
$21.59
52-wk Low
$6.10

Select another date:

Mon, Nov 13 2017

BRIEF-Gemphire Therapeutics reports qtrly loss of $0.82‍​/shr

* Gemphire Therapeutics Inc qtrly loss per share $0.82‍​ Source: (http://bit.ly/2iaJuNF) Further company coverage:

BRIEF-Gemphire announces plans to advance gemcabene into phase 3 clinical development

* Gemphire announces plans to advance gemcabene into phase 3 clinical development

BRIEF-Gemphire Therapeutics Inc files mixed shelf of up to $175 million - SEC filing ‍​

* Gemphire therapeutics inc files mixed shelf of up to $175 million - SEC filing ‍​ Source text: (http://bit.ly/2vRDX2x) Further company coverage:

Select another date: